Edition:
India

Opiant Pharmaceuticals Expands Partnership With Sanofi


Tuesday, 23 Jul 2019 

July 23 (Reuters) - Opiant Pharmaceuticals Inc ::OPIANT PHARMACEUTICALS EXPANDS PARTNERSHIP WITH SANOFI, SIGNS AGREEMENT FOR MANUFACTURING OPNT004 FOR TREATMENT OF ACUTE CANNABINOID OVERDOSE.OPIANT PHARMACEUTICALS INC - OPIANT INTENDS TO REFORMULATE DRINABANT FOR PARENTERAL ADMINISTRATION IN AN EMERGENCY DEPARTMENT SETTING.OPIANT - LICENSED EXCLUSIVE GLOBAL RIGHTS FROM SANOFI FOR DEVELOPMENT AND COMMERCIALIZATION OF DRINABANT FOR EMERGENCY TREATMENT OF ACO.OPIANT - MANUFACTURING WILL BE PERFORMED IN SANOFI ÚJPEST SITE (HUNGARY) ACTING AS A CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATION (CDMO). 

Company Quote

83.72
1.04 +1.26%
17 Oct 2019